Novo Holdings announces acquisition of portfolio company LimmaTech Biologics by Lilly - Novo Holdings
HealthcareMassachusettsAdd-on
Eli Lilly→LimmaTech Biologics
May 26, 2026
Healthcare M&A Deals in Massachusetts
19 dealsTracking 19 healthcare M&A deals in Massachusetts. Recent activity spans Pharmacy, Healthcare Services Other, Medical Devices, Pharmaceuticals. Massachusetts ranks #6 of 41 states for healthcare deal volume.
Boston Scientific buys $1.5B stake in TAVR developer MiRus
HealthcareMassachusettsOther
Boston Scientific→MiRus
May 18, 2026
Create Medicines raises $122M to bolster in vivo CAR-T therapies
HealthcareMassachusetts
Create Medicines
May 14, 2026
T - Chiesi Farmaceutici SpA (0001464415) (Filed by) — SEC SC TO Filing
HealthcareMassachusettsGoing Private
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 13, 2026
T - KalVista Pharmaceuticals, Inc. (0001348911) (Subject) — SEC SC TO Filing
HealthcareMassachusettsGoing Private
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 13, 2026
Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering
HealthcareMassachusettsOther
Odyssey Therapeutics
May 8, 2026
T/A - Apellis Pharmaceuticals, Inc. (0001492422) (Subject) — SEC SC TO Filing
HealthcareMassachusettsMerger
Biogen→Apellis Pharmaceuticals
May 6, 2026
C - KalVista Pharmaceuticals, Inc. (0001348911) (Subject) — SEC SC TO Filing
HealthcareMassachusettsMerger
Chiesi Farmaceutici→KalVista Pharmaceuticals
May 5, 2026
Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
HealthcareMassachusettsOther
Hemab Therapeutics Holdings
May 4, 2026
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO
HealthcareMassachusettsOther
Avalyn Pharma
Apr 30, 2026
Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement
HealthcareMassachusettsMerger
Apr 14, 2026
T - Apellis Pharmaceuticals, Inc. (0001492422) (Subject) — SEC SC TO Filing
HealthcareMassachusettsMerger
Biogen→Apellis Pharmaceuticals
Apr 14, 2026
Boston Scientific closes buyout of Valencia Technologies
HealthcareMassachusettsAdd-on
Boston Scientific→Valencia Technologies
Apr 6, 2026
Biogen, on the heels of a $5.6B buyout, turns its sights to early-stage assets
HealthcareMassachusettsMerger
Biogen→Apellis Pharmaceuticals
Apr 1, 2026
Cyclerion Therapeutics, Inc. — SEC 8-K Filing
HealthcareMassachusettsMerger
Cyclerion Therapeutics
Apr 1, 2026
BOSTON SCIENTIFIC CORP — SEC S-4/A Filing
HealthcareMassachusettsMerger
Boston Scientific→Penumbra
Mar 30, 2026
COLLEGIUM PHARMACEUTICAL, INC — SEC 8-K Filing
HealthcareMassachusettsMerger
Collegium Pharmaceutical→Corium Therapeutics
Mar 19, 2026
Ampersand Capital Partners Acquires Purna Pharmaceuticals
HealthcareMassachusettsPlatform
Ampersand Capital Partners→Purna Pharmaceuticals
Feb 12, 2026
SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO
HealthcareMassachusettsAdd-on
SHINE→Lantheus SPECT business
Jan 2, 2026